NanoSphere Health Sciences Inc.
NSHS
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 175.20K | 161.40K | 157.70K | 162.60K | 156.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 175.20K | 164.40K | 160.70K | 165.60K | 159.60K |
| Operating Income | -175.20K | -164.40K | -160.70K | -165.60K | -159.60K |
| Income Before Tax | -65.20K | -32.10K | -82.10K | 286.60K | 254.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.07 | -0.03 | -0.08 | 0.29 | 0.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -65.20K | -32.10K | -82.10K | 286.60K | 254.40K |
| EBIT | -175.20K | -164.40K | -160.70K | -165.60K | -159.60K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | 0.00 | -0.01 | 0.03 | 0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.01 | 0.00 | -0.01 | 0.03 | 0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 41.10M | 41.10M | 41.10M | 41.10M | 41.10M |
| Average Diluted Shares Outstanding | 41.10M | 41.10M | 41.10M | 41.10M | 41.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |